CN102688272A - Preparation method for medicine for treating anaemia - Google Patents
Preparation method for medicine for treating anaemia Download PDFInfo
- Publication number
- CN102688272A CN102688272A CN201210196507XA CN201210196507A CN102688272A CN 102688272 A CN102688272 A CN 102688272A CN 201210196507X A CN201210196507X A CN 201210196507XA CN 201210196507 A CN201210196507 A CN 201210196507A CN 102688272 A CN102688272 A CN 102688272A
- Authority
- CN
- China
- Prior art keywords
- rhizoma atractylodis
- melanteritum
- medicine
- fine powder
- vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a preparation method for a medicine for treating anaemia. The preparation method comprises the following steps of: slicing rhizoma atractylodis, removing fuzz from cartialgenous, processing tortoise shell with vinegar, calcining copperas and performing plain frying on medicated leaven, wherein the weight ratio of the rhizoma atractylodis to the cartialgenous to the tortoise shell to the copperas to the medicated leaven is 6:1:3:5:5. The copperas calcining step comprises the following process flows of: crushing into a fine powder capable of passing through a sieve of 200 meshes; heating for 20 minutes at the temperature of 160 DEG C; heating to 400 DEG C; calcining for 1 hour; quenching with 0.2 time of rice vinegar; calcining for 1 hour at the temperature of 200 DEG C; extracting the rhizoma atractylodis in eight times weight of water; performing reflux for 2 hours at the steam pressure which is not higher than 0.2MPa; filtering a decoction; adding 5 times weight of water to dregs of the decoction and performing reflux for 2 hours and filtering to obtain filtrate; merging the decorations and filtering; concentrating the filtrate under the conditions that the vacuum degree is 0.05-0.08MPa, the temperature is 70-80 DEG C, and the steam pressure is 0.1-0.2MPa to obtain a paste; crushing the cartialgenous, the tortoise shell, the copperas and the medicated leaven and evenly mixing with the paste; and drying, crushing and pelletizing to obtain the medicine for treating the anaemia. According to the preparation method for the medicine for treating the anaemia, the energy consumption is reduced, the extraction efficiency of effective components of the rhizoma atractylodis is increased, and the controllability of the quality of the medicine is ensured.
Description
Technical field
The present invention relates to treat the medicine of anemia, particularly relating to a kind of is the method for preparing of the Chinese patent medicine of raw material treatment anemia with Chinese medicine.
Background technology
The kind of anemia is a lot, and the cause of disease is complicated, and the traditional Chinese medical science thinks that the source of blood and generation mainly depend on the function of taste and kidney.The medicine of existing treatment anemia is a lot, but the western medicine anemia exists specific aim single, and the state of an illness is prone to repeatedly, be difficult for the shortcoming of radical cure, and the Chinese medicine of existing treatment anemia exists onset slow, the problem that curative effect is low.
The patent No. 95102249.0; Denomination of invention is a kind of Chinese medicine of treating anemia; Disclose with Rhizoma Atractylodis, Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), forged Melanteritum, the stir-fry Massa Medicata Fermentata is a raw material, produces capsule according to conventional method, wherein with Rhizoma Atractylodis water extraction three times volatile oil and decocting liquid concentrated extract; All the other four Chinese medicines are ground into powder adding extractum and process the granule after drying, and it is encapsulated to spray Rhizoma Atractylodis oil then.Prior art has two: 1, the Rhizoma Atractylodis water extraction is got volatile oil and decocting liquid concentrated extract three times, and all the other four Chinese medicines are ground into powder adding extractum and process the granule after drying, and it is encapsulated to spray Rhizoma Atractylodis oil then; 2, the above five tastes, Rhizoma Atractylodis add 8 times of amounts of water and extracted volatile oil 2 hours, and the aqueous solution after distillation device is in addition collected; Medicinal residues add 5 times of amounts of water, decoct 2 hours, merge distillate and decocting liquid, filter, and filtrating is concentrated into the clear paste that relative density is 1.2～1.25 (70 ℃), and is subsequent use; Four flavors such as all the other Massa Medicata Fermentatas are ground into fine powder, add in the clear paste, and it are an amount of to add starch, stirs, and processes granule, and drying is evenly sprayed Rhzoma Atractylodis Lanceae volatile oil in granule, encapsulated (seeing drug standard WS-5528 (B-0528)-2002); The production process that relates in the background technology document exists processing step loaded down with trivial details, and technical parameter is indeterminate, the bigger grade of energy consumption problem more or less.And in preparation Chinese medicine process; Different because of the difference of processing step and technical parameter; Its ingredient of medicine of preparation gained and the drug effect of generation all can have very big difference; That is to say: its quality controllability of Chinese medicine of the treatment anemia of producing according to above production technology is poor, can't effectively guarantee product quality aborning, and then pharmaceutical effectiveness can not get guaranteeing.Imitate and can not get guaranteeing.
Summary of the invention
The purpose of this invention is to provide a kind of is the method for preparing of the Chinese patent medicine of raw material treatment anemia with Chinese medicine.
The present invention realizes through following technical scheme:
A kind of method for preparing of treating the medicine of anemia may further comprise the steps:
(1) medical material pre-treatment: with Rhizoma Atractylodis sections, Cornu Cervi Pantotrichum QUMAO, Carapax Et Plastrum Testudinis is used vinegar system, the Melanteritum calcine, and Massa Medicata Fermentata is fried, and the Rhizoma Atractylodis of wherein cutting into slices, QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), forging Melanteritum, the weight ratio of frying Massa Medicata Fermentata are 6:1:3:5:5; Wherein, Melanteritum calcine step is: clean Melanteritum is ground into the fine powder that can cross 200 mesh sieves, fine powder is warming up to 400 ℃ in heating under 160 ℃ of temperature after 20 minutes again; Calcined 1 hour; With the refining of quenching while hot of the rice vinegar of 0.2 times of Melanteritum weight,, cool and get final product then 200 ℃ of calcinings 1 hour down;
(2) water extraction: get Rhizoma Atractylodis and extracted 2 hours in the condition refluxed of steam pressure≤0.2Mpa after 1 hour with 8 times of weight floodings; Collect volatile oil; Filter decocting liquid, medicinal residues are added 5 times of weight water, 2 hours after-filtration of reflux, extract, get decocting liquid once more; Twice decocting liquid merged after-filtration; Filtrating is 0.05～0.08Mpa in vacuum, and temperature is 70～80 ℃, steam pressure be use spherical concentration tank to carry out vacuum decompression under the condition of 0.1～0.2Mpa to be concentrated in the time of 70 ℃ relative density be that 1.2～1.25 Rhizoma Atractylodis clear paste is subsequent use;
(3) pulverize: will be through QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), the forging Melanteritum of step (1) pre-treatment, fry Massa Medicata Fermentata and mix, be ground into the fine powder that can cross 100 mesh sieves, it is even that the fine powder range estimation does not have caking, no foreign body, color and luster;
(4) granulation is encapsulated: step (3) gained fine powder is added in the Rhizoma Atractylodis clear paste of step (2) gained; Behind the mix homogeneously, drying and crushing is processed granule, and granulation order number is 20 orders; Granule carries out granulate with pelletizing machine; Granulate order number is 20 orders, in three-dimensional motion mixer, evenly sprays Rhzoma Atractylodis Lanceae volatile oil and mixes with granule, and the granule that mixes is encapsulated by the specification of 0.3g/ grain.
Method for preparing of the present invention has been improved the Melanteritum technology for calcining; Improve iron supplement in the preparation effective ingredient---ferrous iron (Fe2+) is in the intravital activity of people; And solubility strengthens, and has improved to the present invention relates to the curative effect of preparation aspect the low diseases of bone marrow hematogenesis such as treatment iron deficiency anemia, aplastic anemia; The process conditions that the present invention carries through accurate control Rhizoma Atractylodis water, and then improve extraction ratio, the quality of strict control medicine improves curative effect.
For a better understanding of the present invention, further set forth the raising of quality controllable and curative effect of the medicine of method for preparing system of the present invention below through Test Example.
1, get the 3 lot sample article that this law makes and carry out the quality standard check, assay is following:
Table 13 lot sample article check result
Sample lot number 20,110,201 20,110,202 20110203
Character is up to specification up to specification
Differentiate that 1. microscopical identification is up to specification up to specification
2. chromatography differentiates that the characteristic speckle of Rhizoma Atractylodis is up to specification up to specification
Check that 1. ferric salt must not surpass 5% and cross 5% and cross 5% and do not cross 5%
2. arsenic salt must not be crossed 5/1000000ths and 5/1000000ths 5/1000000ths not cross 5/1000000ths excessively excessively
3. content uniformity (± 10%) is up to specification up to specification
4. moisture must not surpass 9.0% 7.33% 7.52% 7.28%
5. 22 minutes 19 minutes 20 minutes disintegration (in 30 minutes all disintegrates)
Every of assay contains Melanteritum with FeSO
4Meter>=0.07g 0.089g/ grain 0.091g/ grain 0.086g/ grain
Microbial limit is up to specification up to specification
2, get the sample that this law makes and treat the iron deficiency anemia clinical evaluation, process and result are following:
(1) case standard:
Include standard in---meet the diagnosis of doctor trained in Western medicine iron deficiency anemia; Meeting Chinese medical discrimination is the syndrome of yang deficiency of spleen and kidney patient; Age is at 18-70 between year; Tried voluntarily and the person that signs the Informed Consent Form.
Exclusion standard---merge serious primary disease such as liver (1.5 times of liver function＞normal values), kidney, hemopoietic system, the psychotic; Gestation or preparation gestation, women breast-feeding their children; To this medicine composition allergy sufferers and serious allergic constitution person; Participate in the patient of other clinical medicine tests in nearly 3 months.
(2) test method
This test is followed at random, double blinding, parallel control, multiple center clinical study method; The capsule of selecting method for making of the present invention to make is a trial drug; 95102249.0 patent of invention in the capsule that makes of the preparation process that provides be control drug 1, the capsule that drug standard WS-5528 (B-0528)-2002 [method for making] makes is a control drug 2.
(3) observation index
Demography data---name, sex, age, occupation, nationality, body weight, height, marriage situation (record once before the treatment).
Safety observation---vital sign (temperature pulse respiration, blood pressure, heart rate), routine blood test, routine urinalysis, stool routine examination+occult blood laboratory examination, Electrocardioscopy, liver function (ALT, AST, TBIL, DBIL), renal function (BUN, Cr) inspection, adverse events, symptom, sign that untoward reaction occurred are observed.
Health giving quality observation---1) SF, serum levels of iron, transferrins, total iron binding capacity; 2) tcm syndrome curative effect; 3) variation of traditional Chinese medical science relevant symptoms, picture of the tongue and pulse condition.
(4) observation time point
Relevant S&S: record before the medication and after the medication.
Safety indexes observation: respectively do once (should before medication, check in 1 week in 1 week and after the drug withdrawal, and answer the close observation occurrence of adverse reaction, and carry out record) before and after the treatment.
(5) efficacy assessment standard
Standard formulation with reference to " new Chinese medicine clinical research guideline " " new Chinese medicine treatment iron deficiency anemia clinical research guideline ".
Total mark before therapeutic index (n)=treatment-treatment back total mark * 100%
Total mark before the treatment
Clinical recovery: therapeutic index (integrated value reduction) >=90%.
Produce effects: therapeutic index (integrated value reduction) >=70%,＜90%.
Effectively: therapeutic index (integrated value reduction) >=30%,＜70%.
Invalid: therapeutic index (integrated value reduction)＜30%.
(6) result
According to case inclusion criteria and the exclusion standard in the clinical trial protocol, have 180 routine subject enrollments and get into this test, test group is 60 examples, and matched group 1 is 60 examples, and matched group 2 is 60 examples.Data blind review decision after all 4 weeks of case treatment: data of safety collection (SS) 180 examples, wherein test group is 60 examples, and matched group 1 is 60 examples, and matched group 2 is 60 examples; Complete analysis collection (FAS) 180 examples, wherein test group is 60 examples, and matched group 1 is 60 examples, and matched group 2 is 60 examples; Meet scheme set (PPS) 180 examples 24 weeks, wherein test group is 60 examples, and matched group 1 is 60 examples, and matched group 2 is 60 examples.
Demographic characteristics: average 33.88 years old of 1 age of matched group before the treatment, male's 25 examples, women's 35 examples, the average 168.5cm of height, weight average 63.66kg; Average 34.38 years old of 2 ages of matched group, male's 26 examples, women's 34 examples, the average 168.7cm of height, weight average 65.36kg; Average 35.56 years old of test group age, male's 28 examples, women's 32 examples, the average 169.52cm of height, weight average 66.28kg; The equal not statistically significants of data set differences such as age, sex, height, body weight, nationality, occupation, marital status between test group and matched group (P>0.05), have comparability.
Three groups of medical histories, the course of disease, state of an illness classification, primary disease treatment history, drug allergy histories and merge the equal not statistically significant of disease group differences (P>0.05) have comparability.
Vital sign: matched group 1 is breathed the average 118.11mmHg of systolic pressure, the average 74.85mmHg of diastolic pressure, average 36.51 ℃ of body temperature average 18.66 times before the treatment; Matched group 2 is breathed the average 117.91mmHg of systolic pressure, the average 75.14mmHg of diastolic pressure, average 36.47 ℃ of body temperature average 18.54 times; Test group is breathed average 18.39 times, the average 119.41mmHg of systolic pressure, the average 74.76mmHg of diastolic pressure, average 36.49 ℃ of body temperature; Blood pressure between matched group and test group in the vital sign, breathing, heart rate,, the equal not statistically significant of body temperature group difference (P>0.05), have comparability.
Effectiveness is observed:
SF: after treating for 4 weeks, effective percentage matched group 1 is 44.07%, and matched group 2 is 44.67%, and test group is 64.82%; Through rank test, 4 week of matched group and test group treatment the back group differences statistical significance (P < 0.05) is arranged.
Serum levels of iron: after treating for 4 weeks, effective percentage matched group 1 is 42.16%, and matched group 2 is 41.98%, and test group is 58.5%; Through rank test, 4 week of matched group and test group treatment the back group differences statistical significance (P < 0.05) is arranged.
Transferrins: after treating for 4 weeks, effective percentage matched group 1 is 43.92%, and matched group 2 is 44.07%, and test group is 59.00%; Through rank test, 4 week of matched group and test group treatment the back group differences statistical significance (P < 0.05) is arranged.
Total iron binding capacity: after treating for 4 weeks, effective percentage matched group 1 is 45.78%, and matched group 2 is 46.27%, and test group is 65.14%; Through rank test, 4 week of matched group and test group treatment the back group differences statistical significance (P < 0.05) is arranged.
The tcm syndrome curative effect: after treating for 4 weeks, cure-remarkable-effectiveness rate matched group 1 is 44.44%, and matched group 2 is 46.35%, and test group is 64.86%; Total effective rate matched group 1 is 65.63%, and matched group 2 is 69.35%, and test group is 84.79%; Through rank test, 4 week of matched group and test group treatment the back cure-remarkable-effectiveness rates and the total effective rate group difference statistical significance (P < 0.05) is arranged.
Safety is observed:
Matched group and test group all do not have bad incident and take place.
Medicine of the present invention is formed with natural Chinese medicines, has no side effect, and method for preparing has reduced power consumption; Improve the extraction effect of Rhizoma Atractylodis effective ingredient, guaranteed to produce the quality controllable of medicine; Improved the curative effect of the low disease of bone marrow hematogenesis aspects such as treatment iron deficiency anemia, aplastic anemia.
The specific embodiment
Embodiment 1
A kind of method for preparing of treating the medicine of anemia may further comprise the steps:
(1) medical material pre-treatment: take by weighing the section of 6.3kg Rhizoma Atractylodis, QUMAO Cornu Cervi Pantotrichum 1.05kg, Carapax et Plastrum Testudinis(processed with vinegar) 3.15kg, calcine Melanteritum 5.25kg fries Massa Medicata Fermentata 5.25kg;
Wherein, Melanteritum calcine step is: clean Melanteritum is ground into the fine powder that can cross 200 mesh sieves, fine powder is warming up to 400 ℃ in heating under 160 ℃ of temperature after 20 minutes again, calcined 1 hour; With the refining of quenching while hot of the rice vinegar of 0.2 times of Melanteritum weight, then 200 ℃ of calcinings 1 hour down;
(2) water extraction: get Rhizoma Atractylodis sections with the purified water lixiviate of 50.4kg after 1 hour the condition refluxed extraction of steam pressure 0.2Mpa 2 hours; Collect volatile oil, filter decocting liquid device collection in addition, medicinal residues are added 31.5kg water; 2 hours after-filtration of reflux, extract, get decocting liquid once more; Twice decocting liquid merged the after-filtration 79.9kg that must filtrate, and filtrating is 0.06Mpa in vacuum, and temperature is 72 ℃; Steam pressure be use spherical concentration tank to carry out vacuum decompression under the condition of 0.1Mpa to be concentrated in the time of 70 ℃ relative density be that 1.2～1.25 Rhizoma Atractylodis clear paste is subsequent use, amount to 3.1kg;
(3) pulverize: will be through QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), the forging Melanteritum of step (1) pre-treatment, fry Massa Medicata Fermentata and mix, be ground into the fine powder that can cross 100 mesh sieves, it is even that the fine powder range estimation does not have caking, no foreign body, color and luster;
(4) granulation is encapsulated: step (3) gained fine powder 14.62kg is added among the Rhizoma Atractylodis clear paste 3.1kg of step (2) gained; After closing evenly, drying and crushing is processed granule, and granulation order number is 20 orders; Granule carries out granulate with pelletizing machine; Granulate order number is 20 orders, in three-dimensional motion mixer, evenly sprays Rhzoma Atractylodis Lanceae volatile oil 0.2kg and mixes with granule, and the granule 16.87kg that mixes is encapsulated 70,000 by the specification of 0.3g/ grain.
Embodiment 2
A kind of method for preparing of treating the medicine of anemia may further comprise the steps:
(1) medical material pre-treatment: with Rhizoma Atractylodis sections, Cornu Cervi Pantotrichum QUMAO, Carapax Et Plastrum Testudinis is used vinegar system, the Melanteritum calcine, and Massa Medicata Fermentata is fried, and the Rhizoma Atractylodis of wherein cutting into slices, QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), forging Melanteritum, the weight ratio of frying Massa Medicata Fermentata are 6:1:3:5:5; Wherein, Melanteritum calcine step is: clean Melanteritum is ground into the fine powder that can cross 200 mesh sieves, fine powder is warming up to 400 ℃ in heating under 160 ℃ of temperature after 20 minutes again; Calcined 1 hour; With the refining of quenching while hot of the rice vinegar of 0.2 times of Melanteritum weight,, cool and get final product then 200 ℃ of calcinings 1 hour down;
(2) water extraction: get Rhizoma Atractylodis and extracted 2 hours in the condition refluxed of steam pressure 0.18Mpa after 1 hour with 8 times of weight floodings; Collect volatile oil; Filter decocting liquid, medicinal residues are added 5 times of weight water, 2 hours after-filtration of reflux, extract, get decocting liquid once more; Twice decocting liquid merged after-filtration; Filtrating is 0.05Mpa in vacuum, and temperature is 80 ℃, steam pressure be use spherical concentration tank to carry out vacuum decompression under the condition of 0.15Mpa to be concentrated in the time of 70 ℃ relative density be that 1.2～1.25 Rhizoma Atractylodis clear paste is subsequent use;
(3) pulverize: will be through QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), the forging Melanteritum of step (1) pre-treatment, fry Massa Medicata Fermentata and mix, be ground into the fine powder that can cross 100 mesh sieves, it is even that the fine powder range estimation does not have caking, no foreign body, color and luster;
(4) granulation is encapsulated: step (3) gained fine powder is added in the Rhizoma Atractylodis clear paste of step (2) gained; Behind the mix homogeneously, drying and crushing is processed granule, and granulation order number is 20 orders; Granule carries out granulate with pelletizing machine; Granulate order number is 20 orders, in three-dimensional motion mixer, evenly sprays Rhzoma Atractylodis Lanceae volatile oil and mixes with granule, and the granule that mixes is encapsulated by the specification of 0.3g/ grain.
Embodiment 3
A kind of method for preparing of treating the medicine of anemia may further comprise the steps:
(1) medical material pre-treatment: with Rhizoma Atractylodis sections, Cornu Cervi Pantotrichum QUMAO, Carapax Et Plastrum Testudinis is used vinegar system, the Melanteritum calcine, and Massa Medicata Fermentata is fried, and the Rhizoma Atractylodis of wherein cutting into slices, QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), forging Melanteritum, the weight ratio of frying Massa Medicata Fermentata are 6:1:3:5:5; Wherein, Melanteritum calcine step is: clean Melanteritum is ground into the fine powder that can cross 200 mesh sieves, fine powder is warming up to 400 ℃ in heating under 160 ℃ of temperature after 20 minutes again; Calcined 1 hour; With the refining of quenching while hot of the rice vinegar of 0.2 times of Melanteritum weight,, cool and get final product then 200 ℃ of calcinings 1 hour down;
(2) water extraction: get Rhizoma Atractylodis and extracted 2 hours in the condition refluxed of steam pressure 0.17Mpa after 1 hour, collect volatile oil, filter decocting liquid with 8 times of weight floodings; Medicinal residues are added 5 times of weight water; 2 hours after-filtration of reflux, extract, get decocting liquid once more, and twice decocting liquid merged after-filtration, and filtrating is 0.08Mpa in vacuum; Temperature is 70 ℃, steam pressure be use spherical concentration tank to carry out vacuum decompression under the condition of 0.2Mpa to be concentrated in the time of 70 ℃ relative density be that 1.2～1.25 Rhizoma Atractylodis clear paste is subsequent use;
(3) pulverize: will be through QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), the forging Melanteritum of step (1) pre-treatment, fry Massa Medicata Fermentata and mix, be ground into the fine powder that can cross 100 mesh sieves, it is even that the fine powder range estimation does not have caking, no foreign body, color and luster;
(4) granulation is encapsulated: step (3) gained fine powder is added in the Rhizoma Atractylodis clear paste of step (2) gained; Behind the mix homogeneously, drying and crushing is processed granule, and granulation order number is 20 orders; Granule carries out granulate with pelletizing machine; Granulate order number is 20 orders, in three-dimensional motion mixer, evenly sprays Rhzoma Atractylodis Lanceae volatile oil and mixes with granule, and the granule that mixes is encapsulated by the specification of 0.3g/ grain.
Claims (1)
1. method for preparing of treating the medicine of anemia is characterized in that may further comprise the steps:
(1) medical material pre-treatment: with Rhizoma Atractylodis sections, Cornu Cervi Pantotrichum QUMAO, Carapax Et Plastrum Testudinis is used vinegar system, the Melanteritum calcine, and Massa Medicata Fermentata is fried, and the Rhizoma Atractylodis of wherein cutting into slices, QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), forging Melanteritum, the weight ratio of frying Massa Medicata Fermentata are 6:1:3:5:5;
Wherein, Melanteritum calcine step is: clean Melanteritum is ground into the fine powder that can cross 200 mesh sieves, fine powder is warming up to 400 ℃ in heating under 160 ℃ of temperature after 20 minutes again; Calcined 1 hour; With the refining of quenching while hot of the rice vinegar of 0.2 times of Melanteritum weight,, cool and get final product then 200 ℃ of calcinings 1 hour down;
(2) water extraction: get Rhizoma Atractylodis and extracted 2 hours in the condition refluxed of steam pressure≤0.2Mpa after 1 hour with 8 times of weight floodings; Collect volatile oil; Filter decocting liquid, medicinal residues are added 5 times of weight water, 2 hours after-filtration of reflux, extract, get decocting liquid once more; Twice decocting liquid merged after-filtration; Filtrating is 0.05～0.08Mpa in vacuum, and temperature is 70～80 ℃, steam pressure be use spherical concentration tank to carry out vacuum decompression under the condition of 0.1～0.2Mpa to be concentrated in the time of 70 ℃ relative density be that 1.2～1.25 Rhizoma Atractylodis clear paste is subsequent use;
(3) pulverize: will be through QUMAO Cornu Cervi Pantotrichum, Carapax et Plastrum Testudinis(processed with vinegar), the forging Melanteritum of step (1) pre-treatment, fry Massa Medicata Fermentata and mix, be ground into the fine powder that can cross 100 mesh sieves, it is even that the fine powder range estimation does not have caking, no foreign body, color and luster;
(4) granulation is encapsulated: step (3) gained fine powder is added in the Rhizoma Atractylodis clear paste of step (2) gained; Behind the mix homogeneously, drying and crushing is processed granule, and granulation order number is 20 orders; Granule carries out granulate with pelletizing machine; Granulate order number is 20 orders, in three-dimensional motion mixer, evenly sprays Rhzoma Atractylodis Lanceae volatile oil and mixes with granule, and the granule that mixes is encapsulated by the specification of 0.3g/ grain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210196507XA CN102688272B (en) | 2012-06-15 | 2012-06-15 | Preparation method for medicine for treating anaemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210196507XA CN102688272B (en) | 2012-06-15 | 2012-06-15 | Preparation method for medicine for treating anaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102688272A true CN102688272A (en) | 2012-09-26 |
| CN102688272B CN102688272B (en) | 2013-09-11 |
Family
ID=46854117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210196507XA Active CN102688272B (en) | 2012-06-15 | 2012-06-15 | Preparation method for medicine for treating anaemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102688272B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920834A (en) * | 2012-11-23 | 2013-02-13 | 深圳市佳泰药业股份有限公司 | Lvrong blood nourishing capsule and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121426A (en) * | 1995-03-15 | 1996-05-01 | 王泰麟 | Traditional Chinese medicine for curing anemia |
| CN1368351A (en) * | 2001-02-05 | 2002-09-11 | 杨孟君 | Nano medicine 'Hexue' and its preparing process |
-
2012
- 2012-06-15 CN CN201210196507XA patent/CN102688272B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121426A (en) * | 1995-03-15 | 1996-05-01 | 王泰麟 | Traditional Chinese medicine for curing anemia |
| CN1368351A (en) * | 2001-02-05 | 2002-09-11 | 杨孟君 | Nano medicine 'Hexue' and its preparing process |
Non-Patent Citations (3)
| Title |
|---|
| 刘苹等: "再生障碍性贫血的研究进展", 《临床和实验医学杂志》 * |
| 周江: "陈绍宏运用龟鹿二仙胶治疗慢性再生障碍性贫血的经验", 《世界中医药》 * |
| 王小红等: "生血片在治疗妇产科贫血中的应用(附60例分析)", 《福建医药杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920834A (en) * | 2012-11-23 | 2013-02-13 | 深圳市佳泰药业股份有限公司 | Lvrong blood nourishing capsule and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102688272B (en) | 2013-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110075202A (en) | A kind of qi-blood tonifying Chinese medicine composition and preparation method thereof | |
| CN108686188A (en) | A kind of Chinese medicine composition for treatment of kidney disease | |
| CN100391529C (en) | Preparation for digestant and nourishing-kidney tablets by micropowder technology | |
| CN106265531A (en) | The fresh medicine in a kind of soup side is condensed into corpuscular medicament and preparation method thereof | |
| CN100493578C (en) | Chinese medicine composition for treating thin body and delicate constitution, and preparing method | |
| CN102688272B (en) | Preparation method for medicine for treating anaemia | |
| CN101856490A (en) | Method for preparing Sini decoction granules from unprocessed radix aconiti lateralis | |
| CN101703697B (en) | Chinese patent medicament for treating epilepsy and preparation method thereof | |
| CN113811320A (en) | Plant composition, preparation method and application thereof | |
| CN103392986B (en) | Gerocomia wheat flour and preparation method thereof | |
| CN106667937B (en) | Lycium ruthenicum polysaccharide chewable tablet | |
| CN101829272B (en) | Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof | |
| CN111743968A (en) | Plant composition, preparation method and application thereof | |
| CN105456689A (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of traditional Chinese medicine composition | |
| CN105055851B (en) | A kind of Chinese medicine composition that treating diabetes, its preparation and its application | |
| CN103393938B (en) | Traditional Chinese medicine composition for reducing blood sugar | |
| CN102764338A (en) | Medicine composition for treating renal diseases | |
| CN104922371A (en) | Use of combination in preparation of medicine for treating transient and chronic tic disorder | |
| CN105031219A (en) | Traditional Chinese medicine compound preparation for treating diabetes induced by deficiency of both qi and yin as well as preparation method and application thereof | |
| CN109288896A (en) | A kind of mulberry green tea produced in Anhui Province and preparation method thereof | |
| CN104509855A (en) | Auxiliary hypoglycemic composition and preparation method thereof | |
| CN113616742B (en) | Traditional Chinese medicine composition for treating lung and spleen deficiency of pulmonary diseases and preparation method and application thereof | |
| CN112807390B (en) | Bagged tea with effect of reducing uric acid and preparation method and application thereof | |
| CN105381330A (en) | Method for preparing health care food for diabetic patients | |
| CN115252717A (en) | Wuyi paste suitable for people with qi deficiency constitution, preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180531 Address after: 048000 Fengxiang District, Jincheng, Shanxi Province, No. 9 building 2-201 Patentee after: Han Xiaoping Address before: 030021 15 Li Hua Yuan District, wanBerlin District, Taiyuan, Shanxi 402 Co-patentee before: Han Xiaoping Patentee before: Jia Ru |